Analytics
HIMSS24
Ziv Ofek, cofounder and CEO of MDClone, discusses how GenAI tools may soon make it easier for clinicians to analyze synthetic data themselves if guardrails are in place to ensure that the AI's conclusions are correct.
CasePointer's workforce will join Deloitte, and the company will use the business's software in conjunction with its GovConnect assets to assist its government clients.
Hal Wolf, president and CEO of HIMSS, talks about the top learnings from the 2024 HIMSS European Health Conference & Exhibition in Rome and reveals that HIMSS25 Europe will take place 10-12 June 2025 in Paris.
HIMSS24
Dr. Michal Tzuchman Katz, cofounder and CEO of Kahun, discusses how educating doctors on the source of information for the company's clinical knowledge graph and how the product supports patient care encourage its adoption.
A study published in Clinical Imaging says ChatGPT can simplify radiology reports, but the results differ significantly based on racial context.
Ansys industry director for Healthcare Solutions Thierry Marchal and researcher María Angeles Pérez discuss how combining clinical data and mathematical models can increase precision and expedite treatment plans.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
HIMSS24
Dr. Tim O'Connell, cofounder and CEO of Emtelligent, believes healthcare organizations should not rely solely on AI for business processes and must train models on data sets that represent "all of humanity."
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.